Large-scale testing (Phase 3)Study completedNCT02932943
What this trial is testing
Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 465